Opiant Pharmaceuticals Inc OPNT:NASDAQ

RT Quote | NASDAQ | USD
Last | 02/26/21 EST
12.66quote price arrow down-0.37 (-2.84%)
Volume
30,023
52 week range
6.79 - 14.98

...

Loading . . .

KEY STATS

  • Open12.89
  • Day High13.21
  • Day Low12.35
  • Prev Close12.66
  • 52 Week High14.98
  • 52 Week High Date02/10/21
  • 52 Week Low6.79
  • 52 Week Low Date10/30/20
  • Market Cap53.93M
  • Shares Out4.26M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta0.84
  • 1 Year % Change4.71

RATIOS/PROFITABILITY

  • EPS (TTM)-0.10
  • P/E (TTM)-121.97
  • Fwd P/E (NTM)11.17
  • EBITDA (MRQ)-369,260.00
  • ROE (MRQ)-0.32%
  • Revenue (MRQ)27.37M
  • Gross Margin (MRQ)78.41%
  • Net Margin (MRQ)-0.40%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Opiant Pharmaceuticals Inc News

There is no recent news for this security.

Latest OPNT News From Our Partners

QUOTE FINDER

Profile

MORE
Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company developing medicines for addictions and drug overdose. The Company has developed NARCAN (naloxone hydrochloride) Nasal Spray, a treatment to reverse opioid overdose. The Company’s pipeline includes medicines in development for Opioid Overdose Reversal (OOR), Alcohol Use Disorder (AUD), Opioid Use Disorder (OUD), and Acute Cannabinoid Overdose (ACO). The Company also is focused on other treatment opportunities...
Craig Collard
Chairman
Roger Crystal
President
David O'Toole
Chief Financial Officer
Arvind Agrawal
Executive Vice President
Rahsaan Thompson
General Counsel
Address
201 SANTA MONICA BOULEVARD, SUITE 500
Santa Monica, CA
90401
United States